Medexus Pharmaceuticals Inc. (TSE:MDP – Get Free Report) shares hit a new 52-week high during trading on Thursday . The stock traded as high as C$4.28 and last traded at C$4.04, with a volume of 23487 shares traded. The stock had previously closed at C$4.16.
Medexus Pharmaceuticals Trading Down 3.6%
The firm’s fifty day moving average price is C$3.99 and its 200-day moving average price is C$3.33. The company has a market cap of C$129.52 million, a P/E ratio of -200.50 and a beta of 0.53.
About Medexus Pharmaceuticals
Medexus is a leading specialty pharmaceutical company with a strong North American commercial platform and a growing portfolio of innovative and rare disease treatment solutions. Medexus’s current focus is on the therapeutic areas of hematology and hematology-oncology and rheumatology and allergy.
Further Reading
- Five stocks we like better than Medexus Pharmaceuticals
- MDA Space Targets US Defense Market With $620M Acquisition
- Carnival’s Second Quarter: Is the Stock Still Complicated?
- Domino’s Stock Slides to 52-Week Low as Investors Digest CEO Change
- Microsoft Solves AI’s Biggest Bottleneck With Chevron Deal
Receive News & Ratings for Medexus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medexus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
